You are here
The Which: Clinical Evidence and Ongoing Trials in Anti-Angiogenic Treatments - Hepatocellular Carcinoma
L. Bolondi (Italy)
Luigi Bolondi talks about liver cancer, introducing some of its characteristics, such as abnormal arterial vascularization. The presentation then considers phase III clinical trials and looks to the future of treatment beyond sorafenib.